Vitamin C for sepsis: Questions remain

Affiliations

¹ Intensive Care Unit, Jikei University Hospital, Tokyo, Japan; Australian and New Zealand Intensive Care Research Centre, Monash University School of Public Health and Preventive Medicine, Melbourne, VIC, Australia. Electronic address: tofujii-tky@umin.net.
² Australian and New Zealand Intensive Care Research Centre, Monash University School of Public Health and Preventive Medicine, Melbourne, VIC, Australia; Department of Intensive Care & Hyperbaric Medicine, The Alfred, Melbourne, VIC, Australia.
³ Department of Critical Care, University of Melbourne, Melbourne, VIC, Australia; Preclinical Critical Care Unit, Florey Institute of Neuroscience and Mental Health, Melbourne, Melbourne, VIC, Australia.

Editorial

Tomoko Fujii et al. Anaesth Crit Care Pain Med. 2022 Dec.

. 2022 Dec;41(6):101151.

doi: 10.1016/j.accpm.2022.101151. Epub 2022 Sep 6.

¹ Intensive Care Unit, Jikei University Hospital, Tokyo, Japan; Australian and New Zealand Intensive Care Research Centre, Monash University School of Public Health and Preventive Medicine, Melbourne, VIC, Australia. Electronic address: tofujii-tky@umin.net.
² Australian and New Zealand Intensive Care Research Centre, Monash University School of Public Health and Preventive Medicine, Melbourne, VIC, Australia; Department of Intensive Care & Hyperbaric Medicine, The Alfred, Melbourne, VIC, Australia.
³ Department of Critical Care, University of Melbourne, Melbourne, VIC, Australia; Preclinical Critical Care Unit, Florey Institute of Neuroscience and Mental Health, Melbourne, Melbourne, VIC, Australia.

No abstract available

Keywords: LOVIT trial; Sepsis; Vitamin C.

Comment on

Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit.
Lamontagne F, Masse MH, Menard J, Sprague S, Pinto R, Heyland DK, Cook DJ, Battista MC, Day AG, Guyatt GH, Kanji S, Parke R, McGuinness SP, Tirupakuzhi Vijayaraghavan BK, Annane D, Cohen D, Arabi YM, Bolduc B, Marinoff N, Rochwerg B, Millen T, Meade MO, Hand L, Watpool I, Porteous R, Young PJ, D'Aragon F, Belley-Cote EP, Carbonneau E, Clarke F, Maslove DM, Hunt M, Chassé M, Lebrasseur M, Lauzier F, Mehta S, Quiroz-Martinez H, Rewa OG, Charbonney E, Seely AJE, Kutsogiannis DJ, LeBlanc R, Mekontso-Dessap A, Mele TS, Turgeon AF, Wood G, Kohli SS, Shahin J, Twardowski P, Adhikari NKJ; LOVIT Investigators and the Canadian Critical Care Trials Group. Lamontagne F, et al. N Engl J Med. 2022 Jun 23;386(25):2387-2398. doi: 10.1056/NEJMoa2200644. Epub 2022 Jun 15. N Engl J Med. 2022. PMID: 35704292 Clinical Trial.